263700.KQ Carelabs Co.Ltd
- Market cap
- KRW 38.4B
- P/E
- -
- P/B
- 0.58x
- ROE
- -6.0%
- Dividend yield
- 1.34%
- Fundamental score
- 1.8/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 263700.KQ undervalued?
Graham numberThe Graham number of Carelabs Co.Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Carelabs Co.Ltd fundamental analysis
10 of 21 checks passedROE 0/2
Low return on equity (-6.0%), below 10%.
ROA 0/1
Return on assets (-4.1%) is below the industry median (1.4%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 1/1
Last year's EPS growth (194.6%) is above the 5-year average (31.5% a year).
Earnings Growth vs Industry 1/1
Last year's EPS growth (194.6%) is above the industry median (1.8%).
Revenue Growth 0/2
Revenue shrank 2.3% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 1/2
Cash covers 1.4 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 1/1
Price to book (0.6x) is below the industry median (0.9x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 1/2
Dividend yield (1.3%) is above the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 1/1
Dividends paid grew over the past 5 years.
Payout Ratio 1/1
Payout ratio is 2.7%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Carelabs Co.Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Carelabs Co.Ltd
Carelabs Co.,Ltd operates as a healthcare and beauty care platform company in South Korea. The company offers healthcare IT services, such as hospital information services, hospital customer management software, and digital marketing solutions. It provides BABITALK, a plastic surgery information platform; Medijob, which provides human resources to hospitals; VIBE RC, a digital marketing platform; and BNK Lab that provides dating app services. The company also offers GOODOC, …
Full company profileCarelabs Co.Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Carelabs Co.Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 18.6B | 39.3B | 54.4B | 68.3B | 76.7B | 93.9B | 87.6B | 81.8B | 83.2B | 81.7B | 75.8B |
| Gross Profit | 18.6B | 39.3B | 54.3B | 66.0B | 73.5B | 89.3B | 84.6B | 79.7B | 82.1B | 80.1B | 74.0B |
| Operating Income | 2.08B | 6.26B | 5.07B | 2.18B | 1.42B | 1.15B | -17.4B | -15.5B | -10.7B | -2.88B | -96.0M |
| EBITDA | - | - | - | - | - | - | -20.3B | -14.2B | -12.4B | 27.7B | 2.97B |
| Net Income | 1.93B | 4.79B | 3.55B | 583M | 4.33B | 1.25B | -26.1B | -24.5B | -20.3B | 19.2B | -4.00B |
| EPS | 223 | 516 | 288 | 46 | 251 | 73 | -1,434 | -1,261 | -1,045 | 989 | -206 |
| Balance Sheet | |||||||||||
| Total Assets | 15.9B | 39.8B | 125B | 127B | 132B | 199B | 181B | 162B | 143B | 107B | 98.6B |
| Total Liabilities | 5.46B | 16.4B | 64.9B | 64.9B | 33.9B | 96.3B | 96.1B | 93.7B | 94.8B | 32.8B | 26.0B |
| Shareholders' Equity | 10.4B | 23.5B | 59.7B | 62.3B | 98.1B | 102B | 84.6B | 68.5B | 48.4B | 68.5B | 66.7B |
| Cash & Short-term Investments | 3.29B | 10.6B | 42.9B | 36.1B | 51.2B | 63.8B | 35.1B | 30.2B | 41.1B | 39.8B | 20.2B |
| Total Debt | - | - | - | 15.5B | 14.3B | - | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 2.63B | 2.92B | 3.60B | 4.46B | 11.3B | 4.30B | -6.24B | -10.6B | -1.89B | 990M | -9.74B |
| Capital Expenditure | 444M | 159M | 6.65B | 1.46B | 910M | 3.67B | 4.10B | 1.92B | 2.49B | 16.3B | 4.82B |
| Free Cash Flow | - | - | - | 5.71B | 9.54B | 624M | -10.3B | -12.5B | -4.38B | -15.3B | -14.6B |
| Ratios | |||||||||||
| ROE | 18.6% | 20.4% | 5.9% | 0.9% | 4.4% | 1.2% | -30.9% | -35.7% | -41.9% | 28.0% | -6.0% |
| ROA | 12.2% | 12.0% | 2.9% | 0.5% | 3.3% | 0.6% | -14.5% | -15.1% | -14.2% | 17.9% | -4.1% |
| Net Profit Margin | 10.4% | 12.2% | 6.5% | 0.9% | 5.6% | 1.3% | -29.8% | -29.9% | -24.4% | 23.5% | -5.3% |
| Debt to Equity | - | - | - | 0.25x | 0.15x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Carelabs Co.Ltd dividends
- Dividend yield
- 1.34%
- Forward dividend
- -
- Payout ratio
- 2.7%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 514M | 26 | 2.7% |
| 2024 | KRW 490M | 25 | - |
| 2023 | KRW 490M | 25 | - |
| 2022 | KRW 490M | 27 | - |
| 2021 | - | - | - |
| 2020 | KRW 294M | 17 | 6.8% |
| 2019 | KRW 294M | 23 | 50.5% |
| 2018 | KRW 294M | 24 | 8.3% |
| 2017 | KRW 294M | 32 | 6.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Jul 16, 2020.
Who owns Carelabs Co.Ltd
- Insiders 32.84%
- Institutions 0.00%
- Public & others 67.16%
- Shares outstanding 19.4M
- Free float 12.8M
Carelabs Co.Ltd company profile
- Company name
- Carelabs Co.Ltd
- Ticker
- 263700.KQ
- ISIN
- KR7263700007
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Oil, Gas & Consumable Fuels
- Employees
- 123
- Fiscal year end
- December
- Address
- Care-Lab Tower, Seoul, South Korea
- Phone
- 82 2 6929 2340
- Website
- carelabs.co.kr
About Carelabs Co.Ltd
Carelabs Co.,Ltd operates as a healthcare and beauty care platform company in South Korea. The company offers healthcare IT services, such as hospital information services, hospital customer management software, and digital marketing solutions. It provides BABITALK, a plastic surgery information platform; Medijob, which provides human resources to hospitals; VIBE RC, a digital marketing platform; and BNK Lab that provides dating app services. The company also offers GOODOC, a healthcare integrated platform that allows to search, review, reserve, receive, and follow-up management of various medical services, such as hospitals/pharmacies/beauty based on a mobile environment; and BeautyCon, a multilingual AI molding platform that analyzes user information and usage behavior through artificial intelligence and recommends domestic plastic surgeons, doctors, and procedures suitable for users. In addition, it manufactures and supplies solutions for hospital customers and operation management; develops and distributes health functional foods and nutritional supplements; and develops various customer service solutions, as well as provides IT solutions to pharmacies and hospitals; management consulting, marketing, and medical device distribution services; O2O commerce for beauty tours and concierge services for foreign patients. The company was formerly known as Vibe ALS Corporation and changed its name to Carelabs Co.,Ltd in November 2016. Carelabs Co.,Ltd was founded in 2011 and is based in Seoul, South Korea.
Carelabs Co.Ltd management
3- Young-Seok GoExecutive Officer
- Min-Kyung LeeCSO, CEO & Executive Director · born 1989
- Mr. JiMan KimExecutive Director · born 1971